Company Filing History:
Years Active: 2019-2023
Title: Laura Deming: Innovator in Cancer Therapeutics
Introduction
Laura Deming is a prominent inventor based in Palo Alto, CA, who has made significant contributions to the field of cancer therapeutics. She is known for her innovative approaches to targeting cancer cells and enhancing immune responses. With a total of 2 patents, her work is paving the way for new treatments in oncology.
Latest Patents
Deming's latest patents focus on constructs having a signal-regulatory protein α (SIRP-α) domain or variant thereof. These constructs are designed to target specific cells, such as cancer cells or immune cells, to increase phagocytosis and eliminate regulatory T-cells. The SIRP-α constructs include a high-affinity SIRP-α D1 domain that binds CD47 with greater affinity than the wild-type SIRP-α. The polypeptides or constructs may also include a SIRP-α D1 variant fused to an Fc domain monomer, human serum albumin, an albumin-binding peptide, or a polyethylene glycol polymer. These compositions aim to provide effective treatments for diseases like cancer.
Career Highlights
Laura Deming is currently associated with Alx Oncology Inc., where she continues to develop her innovative ideas into practical applications. Her work is characterized by a strong focus on improving cancer treatment methodologies through scientific research and development.
Collaborations
Some of her notable coworkers include Jaume Pons and Corey Goodman, who contribute to her research efforts and the advancement of cancer therapeutics.
Conclusion
Laura Deming is a trailblazer in the field of cancer research, with her innovative patents and collaborations driving forward the development of effective cancer treatments. Her contributions are vital to the ongoing fight against cancer, showcasing the importance of innovation in medical science.